Mismatch repair protein immunohistochemistry: a useful population screening strategy for Lynch syndrome
详细信息 查看全文
- 作者：Eva Musulé ; n ; MD ; emusulen@hotmail.com" class="auth_mail ; Carolina Sanz ; PhD ; Ana Marí ; a Muñ ; oz-Má ; rmol ; PhD ; Aurelio Ariza ; MD
- 关键词：Lynch syndrome ; Immunohistochemistry ; Mismatch repair protein ; Population screening ; Colorectal carcinoma
- 刊名：Human Pathology
- 出版年：July 2014
- 年：2014
- 卷：45
- 期：7
- 页码：1388-1396
- 全文大小：1121 K
文摘
Lynch syndrome (LS), the most frequent form of hereditary colorectal cancer, shows a highly penetrant, autosomal dominant pattern of inheritance. Distinction of LS colorectal carcinoma instances from the much more common sporadic colorectal carcinoma cases is of paramount importance. Revised Bethesda Guidelines were developed to diagnose LS by evaluating a combination of clinical and pathologic data. The aim of the present study was to evaluate the usefulness of the pathology items included in the Revised Bethesda Guidelines. We have prospectively studied a series of 1624 consecutive colorectal carcinomas with an algorithm including immunohistochemical analysis of mismatch repair proteins and molecular study of microsatellite instability and BRAF c.1799 T > A (p.V600E) gene mutations. Patients with tumors showing LS features were referred for germline mutation analysis. By applying our algorithmic approach, we were able to identify LS features in 89 colorectal cancer patients, of whom only 27 met Revised Bethesda Guidelines pathology criteria. Of the 89 patients, 47 were then studied at the Genetic Counseling Unit, and LS was confirmed in 18, of whom 7 had not been identified by the Revised Bethesda Guidelines. Our study shows that the Revised Bethesda Guidelines failed to detect 70% of patients at risk of LS. Our algorithmic approach is a realistic and effective tool for LS identification. We strongly recommend the implementation of universal population screening for LS among all patients with newly diagnosed colorectal carcinoma.